Harnessing epigenetics for breast cancer therapy: The role of DNA methylation, histone modifications, and MicroRNA

J Szczepanek, M Skorupa, J Jarkiewicz-Tretyn… - International Journal of …, 2023 - mdpi.com
Breast cancer exhibits various epigenetic abnormalities that regulate gene expression and
contribute to tumor characteristics. Epigenetic alterations play a significant role in cancer …

Hereditary colorectal, gastric, and pancreatic cancer: comprehensive review

TT Seppälä, RA Burkhart, BW Katona - BJS open, 2023 - academic.oup.com
Background Inheritance patterns show familial clustering of gastrointestinal cancers, and
multiple germline conditions have now been identified that predispose to colorectal, gastric …

Delineating intra-tumoral heterogeneity and tumor evolution in breast cancer using precision-based approaches

KR Xulu, EE Nweke, TN Augustine - Frontiers in Genetics, 2023 - frontiersin.org
The burden of breast cancer continues to increase worldwide as it remains the most
diagnosed tumor in females and the second leading cause of cancer-related deaths. Breast …

Gender-Specific Genetic Predisposition to Breast Cancer: BRCA Genes and Beyond

V Valentini, A Bucalo, G Conti, L Celli, V Porzio… - Cancers, 2024 - mdpi.com
Simple Summary The role of gender in oncology is an issue that is starting to be recognized
as being of extreme importance in the last few years. While breast cancer is commonly …

[HTML][HTML] Radiosensitisation by olaparib through focused ultrasound delivery in a diffuse midline glioma model

J Bianco, MAC Bruin, M Derieppe, HC Besse… - Journal of Controlled …, 2023 - Elsevier
Background and purpose Diffuse midline glioma H3K27-altered (DMG) is an aggressive,
inoperable, predominantly paediatric brain tumour. Treatment strategies are limited …

FANCM promotes PARP inhibitor resistance by minimizing ssDNA gap formation and counteracting resection inhibition

Z Liu, H Jiang, SY Lee, N Kong, YW Chan - Cell Reports, 2024 - cell.com
Poly (ADP-ribose) polymerase inhibitors (PARPis) exhibit remarkable anticancer activity in
tumors with homologous recombination (HR) gene mutations. However, the role of other …

DNA repair pathways in breast cancer: from mechanisms to clinical applications

M Tufail - Breast Cancer Research and Treatment, 2023 - Springer
Background Breast cancer (BC) is a complex disease with various subtypes and genetic
alterations that impact DNA repair pathways. Understanding these pathways is essential for …

MAGI1 Prevents Senescence and Promotes the DNA Damage Response in ER+ Breast Cancer

J Wörthmüller, S Disler, S Pradervand, F Richard… - Cells, 2023 - mdpi.com
MAGI1 acts as a tumor suppressor in estrogen receptor-positive (ER+) breast cancer (BC),
and its loss correlates with a more aggressive phenotype. To identify the pathways and …

Advancements in targeting tumor suppressor genes (p53 and BRCA 1/2) in breast cancer therapy

Chahat, N Nainwal, Y Murti, S Yadav, P Rawat… - Molecular Diversity, 2024 - Springer
Globally, among numerous cancer subtypes, breast cancer (BC) is one of the most prevalent
forms of cancer affecting the female population. A female's family history significantly …

Global trends in BRCA-related breast cancer research from 2013 to 2022: A scientometric analysis

Y Huang, D Zheng, Q Yang, J Wu, H Tian, Z Ji… - Frontiers in …, 2023 - frontiersin.org
Introduction Since the mid-2000s, breast cancer incidence among women has slowly
increased at about 0.5% per year. In the last three decades, Breast Cancer Susceptibility …